Literature DB >> 21514924

Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.

Juan Fortea1, Roser Sala-Llonch, David Bartrés-Faz, Albert Lladó, Cristina Solé-Padullés, Beatriz Bosch, Anna Antonell, Jaume Olives, Raquel Sanchez-Valle, Jose L Molinuevo, Lorena Rami.   

Abstract

BACKGROUND: Establishing the relationship between cerebrospinal fluid (CSF) ß-amyloid 1-42 (Aß) and cortical thickness (CTh) would represent a major step forward in the understanding of the Alzheimer's disease (AD) process. We studied this relationship in a group of healthy control subjects and subjects with subjective memory complaints with preserved cognitive function at neuropsychological testing.
METHODS: In this cross-sectional study, 33 individuals (17 healthy control subjects and 16 subjects with subjective memory complaints) underwent structural 3-Tesla magnetic resonance image scanning and a spinal tap. Cerebrospinal fluid Aß was measured by enzyme-linked immunosorbent assay. The relationship between CSF Aß values and CTh in several regions of interest, both susceptible and unrelated to AD pathology, was analyzed with a curve fit analysis and CTh difference maps were derived from group comparisons.
RESULTS: Dichotomizing the whole sample according to Aß values (cutoff 500 pg/mL), we found the expected cortical thinning in Aß positive subjects in temporoparietal areas (p < .05 corrected). When analyzing the relationship between CSF Aß and CTh in AD-susceptible regions, we found a significant inverted U-shaped relationship (quadratic). Therefore, the sample was further divided into tertiles (according to CSF Aß values) to perform subsequent subgroup comparisons. Increased CTh in temporoparietal areas and precuneus (p < .05 corrected) was found in the middle Aß tertile (CSF Aß between 416 and 597 pg/mL) when compared with the high Aß tertile (616-881 pg/mL).
CONCLUSIONS: The relationship between Aß and CTh in preclinical stages may not be linear. Cortical thickness in temporoparietal and precuneus regions is greater in subjects with transitional CSF Aß values.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514924     DOI: 10.1016/j.biopsych.2011.02.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  45 in total

1.  APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.

Authors:  Shannon L Risacher; Sungeun Kim; Kwangsik Nho; Tatiana Foroud; Li Shen; Ronald C Petersen; Clifford R Jack; Laurel A Beckett; Paul S Aisen; Robert A Koeppe; William J Jagust; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Andrew J Saykin
Journal:  Alzheimers Dement       Date:  2015-05-07       Impact factor: 21.566

Review 2.  Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.

Authors:  S Duke Han; Caroline P Nguyen; Nikki H Stricker; Daniel A Nation
Journal:  Neuropsychol Rev       Date:  2017-05-11       Impact factor: 7.444

Review 3.  A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.

Authors:  Frank Jessen; Rebecca E Amariglio; Martin van Boxtel; Monique Breteler; Mathieu Ceccaldi; Gaël Chételat; Bruno Dubois; Carole Dufouil; Kathryn A Ellis; Wiesje M van der Flier; Lidia Glodzik; Argonde C van Harten; Mony J de Leon; Pauline McHugh; Michelle M Mielke; Jose Luis Molinuevo; Lisa Mosconi; Ricardo S Osorio; Audrey Perrotin; Ronald C Petersen; Laura A Rabin; Lorena Rami; Barry Reisberg; Dorene M Rentz; Perminder S Sachdev; Vincent de la Sayette; Andrew J Saykin; Philip Scheltens; Melanie B Shulman; Melissa J Slavin; Reisa A Sperling; Robert Stewart; Olga Uspenskaya; Bruno Vellas; Pieter Jelle Visser; Michael Wagner
Journal:  Alzheimers Dement       Date:  2014-05-03       Impact factor: 21.566

4.  Longitudinal gray-matter volume change in the default-mode network: utility of volume standardized with global gray-matter volume for Alzheimer's disease: a preliminary study.

Authors:  Masami Goto; Osamu Abe; Shigeki Aoki; Naoto Hayashi; Hiroshi Ohtsu; Hidemasa Takao; Tosiaki Miyati; Hiroshi Matsuda; Fumio Yamashita; Takeshi Iwatsubo; Harushi Mori; Akira Kunimatsu; Kenji Ino; Keiichi Yano; Kuni Ohtomo
Journal:  Radiol Phys Technol       Date:  2014-09-27

Review 5.  Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.

Authors:  Anders M Fjell; Kristine B Walhovd
Journal:  Mol Neurobiol       Date:  2011-12-27       Impact factor: 5.590

6.  Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.

Authors:  Christine L Tardif; Gabriel A Devenyi; Robert S C Amaral; Sandra Pelleieux; Judes Poirier; Pedro Rosa-Neto; John Breitner; M Mallar Chakravarty
Journal:  Hum Brain Mapp       Date:  2017-11-21       Impact factor: 5.038

Review 7.  PET amyloid-beta imaging in preclinical Alzheimer's disease.

Authors:  Andrei G Vlassenko; Tammie L S Benzinger; John C Morris
Journal:  Biochim Biophys Acta       Date:  2011-11-12

8.  Brain structural profile of multiple system atrophy patients with cognitive impairment.

Authors:  Eleonora Fiorenzato; Luca Weis; Klaus Seppi; Marco Onofrj; Pietro Cortelli; Stefano Zanigni; Caterina Tonon; Horacio Kaufmann; Timothy Michael Shepherd; Werner Poewe; Florian Krismer; Gregor Wenning; Angelo Antonini; Roberta Biundo
Journal:  J Neural Transm (Vienna)       Date:  2016-10-24       Impact factor: 3.575

Review 9.  What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

Authors:  Anders M Fjell; Linda McEvoy; Dominic Holland; Anders M Dale; Kristine B Walhovd
Journal:  Prog Neurobiol       Date:  2014-02-16       Impact factor: 11.685

10.  Diffusion MRI biomarkers of white matter microstructure vary nonmonotonically with increasing cerebral amyloid deposition.

Authors:  Jian W Dong; Ileana O Jelescu; Benjamin Ades-Aron; Dmitry S Novikov; Kent Friedman; James S Babb; Ricardo S Osorio; James E Galvin; Timothy M Shepherd; Els Fieremans
Journal:  Neurobiol Aging       Date:  2020-01-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.